WAVEMAN · COMPANY

MTD · Mettler Toledo International Inc/

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475

← ALL COMPANIES

MTD

Name: METTLER TOLEDO INTERNATIONAL INC/ (MTD) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

METTLER TOLEDO INTERNATIONAL INC/

MEDICAL DEVICES · LABORATORY ANALYTICAL INSTRUMENTS · CIK 0001037646

FORM 144 · 3☆ WATCH

INSIDER NET · 180D

-$6.1M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

332

13F, latest reported quarter

REVENUE GROWTH

+4.0%

XBRL, annual

NET MARGIN

21.6%

CONVERSIONS · 180D

codes C/M, not in net · $2.8M priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$6.1M over 180 days

-$6.1M over 90 days

below 77% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

332 funds added or opened last quarter

more than 85% of Medical Devices

REVENUE

+4.0% year over year

below 62% of Medical Devices

MARGIN

21.6% net margin

more than 95% of Medical Devices

BUYBACKS

$412.5M repurchased, FY to 2026-06-30

more than 81% of Medical Devices

SHORT

3.9% of shares outstanding short · 4.2 days to cover · settled 2026-07-31

more than 55% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$6.1M across 4 people in 180 days.

332 funds added or opened positions in the latest 13F quarter, of 807 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +7.2%

+7.2%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $6.1M sold by insiders over 180 days, 332 funds added last quarter, $2.4M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS SIBN WRBY ISRG TXG DXCM EW TMDX OM

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, METTLER TOLEDO INTERNATIONAL INC/ insiders sold a net $6.1M of stock across 496 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER

FILED

VALUE

Kaltenbach Patrick

President and CEO

SELL

2026-08-27

942.0

$1.3M

SALICE THOMAS P

Director

SELL

2026-08-05

417.0

$600.7K

Vadala Shawn

Chief Financial Officer

SELL

2026-08-03

2,240.0

$3.2M

Keller Gerry

Head of Process Analytics

SELL

2026-08-03

240.0

$342.5K

SALICE THOMAS P

Director

SELL

2026-08-03

415.0

$599.5K

496 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 491 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

1,882,344.0 sh

$2.4B

Capital International Investors

1,521,543.0 sh

$1.9B

VANGUARD CAPITAL MANAGEMENT LLC

1,319,636.0 sh

$1.7B

VANGUARD PORTFOLIO MANAGEMENT LLC

1,010,490.0 sh

$1.3B

STATE STREET CORP

951,679.0 sh

$1.2B

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Thomas Salice

FILED 2026-08-05

$600.7K

Thomas Salice

FILED 2026-08-03

$599.5K

Michael Kelly

FILED 2026-07-28

$1.2M

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

PAPP SMALL & MID-CAP GROWTH FUND

$2.6M POSITION · AS OF 2026-02-28

5.6%

Virtus KAR Health Sciences Fund

$3.8M POSITION · AS OF 2026-03-31

4.2%

Baron Health Care Fund

$4.8M POSITION · AS OF 2026-03-31

4.0%

BARON ASSET FUND

$108.0M POSITION · AS OF 2026-03-31

3.3%

iShares Health Innovation Active ETF

$312.8K POSITION · AS OF 2026-04-30

3.1%

NYLI PineStone U.S. Equity Fund

$12.5M POSITION · AS OF 2026-04-30

3.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$4.0B	$3.9B	$3.8B	$3.9B
GROSS PROFIT	$2.4B	$2.3B	$2.2B	$2.3B
NET INCOME	$869.2M	$863.1M	$788.8M	$872.5M
EPS (DILUTED)	42.05	40.48	35.90	38.41
OPERATING CASH FLOW	$955.8M	$968.3M	$965.9M	$859.1M
CASH	—	—	$69.8M	$96.0M
LONG-TERM DEBT	$2.1B	$1.8B	$1.9B	$1.9B
BUYBACKS	$800.0M	$850.0M	$900.0M	$1.1B

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE